Creatine is Cooling — Buyers Are Quietly Moving
After a volatile 18 months, creatine monohydrate is showing signs of price relief. Chinese export costs have softened, and spot pricing is reflecting a more stable pipeline. But seasoned buyers know this pattern — a quiet dip, short-lived, before the next production or freight bottleneck tightens things again.
For formulators and contract manufacturers still running creatine SKU's, now is the moment to take position. Lower volume lanes (like creatine nitrate or creatine HCI) aren't showing the same drop yet — but they follow monohydrate directionally.
Invenex has local and inbound stock under review. Bulk buyers may benefit from pre-allocation while pricing holds.
